Search

everythinglearnresearchcommunity

for

Search:↓

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Testosterone affects brain behavior in complex and varied ways.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

Atopic dermatitis is linked to obesity, especially in severe cases.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Platelet-rich plasma (PRP) is an effective treatment for hair loss that involves scalp injections and requires ongoing maintenance.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

A new method improves the accuracy and reliability of language models by up to 42%.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Transgender individuals face insurance barriers to gender-affirming surgery, needing policy reforms for better access.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

Gender and social factors, not just biology, affect COVID-19 death rates.

Baldness challenged men's self-image and masculinity in Britain from the late 19th to early 20th centuries, leading to a market for hair loss treatments.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Females with pattern hair loss have more occipital involvement than males.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

There is unequal access to gender-affirming surgeries in Canada, with a need for better coverage and specialized programs.

Men and patients on atypical antipsychotics have better mental functioning and quality of life.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.